Nima Farzan
Director/Board Member en KEROS THERAPEUTICS, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Nima M.
Farzan is an Independent Director at Keros Therapeutics, Inc. and a Trustee at The Hamlin School.
Previously, he served as the President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018.
He was also the President & Chief Executive Officer at Paxvax Corp.
Additionally, he held the position of President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024.
Mr. Farzan has also worked as the Director-Disease Area Strategy at Novartis AG and as the Director-Strategic Marketing at DoubleTwist, Inc. He started his career as an Associate at The Boston Consulting Group, Inc. and later became the Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc. He is a Member of the Coalition for Epidemic Preparedness Innovations.
Mr. Farzan completed his undergraduate studies at Stanford University and holds an MBA from Harvard Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KINNATE BIOPHARMA, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
KEROS THERAPEUTICS, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Nima Farzan
| Empresas | Cargo | Inicio |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 |
| The Hamlin School | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Nima Farzan.
| Empresas | Cargo | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Chief Executive Officer | 03/04/2024 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/10/2018 |
DoubleTwist, Inc.
 DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA. | Sales & Marketing | 01/01/1999 |
| Paxvax Corp. | Chief Executive Officer | - |
| Coalition for Epidemic Preparedness Innovations | Corporate Officer/Principal | - |
Formación de Nima Farzan.
| Stanford University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| KEROS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
DoubleTwist, Inc.
DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA. | Commercial Services |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
| The Hamlin School | |
| Coalition for Epidemic Preparedness Innovations | |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
| Paxvax Corp. |
- Bolsa de valores
- Insiders
- Nima Farzan
